CVS Health Corporation (CVS)
| Market Cap | 85.34B |
| Revenue (ttm) | 376.74B |
| Net Income (ttm) | 5.28B |
| Shares Out | 1.27B |
| EPS (ttm) | 4.19 |
| PE Ratio | 16.10 |
| Forward PE | 10.84 |
| Dividend | $2.66 (3.94%) |
| Ex-Dividend Date | Apr 22, 2025 |
| Volume | 14,304,117 |
| Open | 69.95 |
| Previous Close | 69.45 |
| Day's Range | 67.05 - 70.23 |
| 52-Week Range | 43.56 - 72.51 |
| Beta | 0.60 |
| Analysts | Buy |
| Price Target | 73.07 (+8.32%) |
| Earnings Date | May 1, 2025 |
About CVS
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]
Financial Performance
In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.
Financial StatementsAnalyst Forecast
According to 15 analysts, the average rating for CVS stock is "Buy." The 12-month stock price forecast is $73.07, which is an increase of 8.32% from the latest price.
News
Breaking down 3 takeaways from healthcare earnings
Yahoo Finance Senior Health Reporter Anjalee Khemlani joins the Wealth team in breaking down the biggest themes she is seeing in the healthcare space from this earnings season, ranging from CVS Health...
DOJ Files Complaint Against Aetna, eHealth, Others, Alleging Medicare Advantage Kickbacks
The DOJ alleges in its complaint that CVS Health-unit Aetna, Elevance Health and Humana paid the kickbacks to brokers eHealth, GoHealth and SelectQuote in exchange for enrollments into the insurers' M...
CVS Caremark To Place Novo Nordisk's Wegovy On Preferred Coverage For GLP-1 Weight Loss Treatment
Novo Nordisk A/S NVO announced that CVS Health Inc's CVS CVS Caremark, a Pharmacy Benefit Manager (PBM), has decided that Wegovy (semaglutide) injection 2.4 mg will soon be the preferred GLP-1 medicin...
CVS Health Excludes Zepbound: Why Eli Lilly's 11%+ Drop Looks Overdone
Eli Lilly and Company's stock fell over 11% after CVS Caremark excluded Lilly's obesity drug Zepbound from its standard commercial formularies starting July 1, 2025. The market overreacted to CVS's ex...
CVS earnings: Things are finally clicking for the healthcare giant
CVS (CVS) stock jumped after beating first quarter earnings and revenue expectations. Jefferies Healthcare Services equity research analyst Brian Tanquilut explains how CVS's margin recovery and busin...
CVS Health: Why I'm Not Buying The Post-Earnings Share Buoyancy
CVS Health Corporation's Q1 2025 earnings show strong growth, with revenues up 7% YoY and adjusted EPS up 72%, but caution is advised for the long-term outlook. Despite positive quarterly results, CVS...
CVS Health (CVS) Q1 2025 Earnings Call Transcript
CVS Health Corporation (NYSE:CVS) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET Company Participants David Joyner - President, Chief Executive Officer Tom Cowhey - Executive Vice President,...
CVS Health Partners With Wegovy Maker Novo Nordisk, Hikes 2025 Guidance
CVS Health Corp CVS reported first-quarter sales of $94.59 billion on Thursday, beating the consensus of $93.64 billion.
QCOM Earnings Sell-Off, CVS Turnaround Continues, LLY Disappoints
While Microsoft (MSFT) and Meta Platforms (META) shined in the Big Tech space, Diane King Hall turns to a mixed earnings picture elsewhere on Wall Street. CVS Health (CVS) posted an earnings beat, rai...
CVS Health Stock Surges as Q1 Results Handily Top Estimates
CVS Health (CVS) shares powered 9% higher before the bell Thursday after the pharmacy and healthcare giant's first-quarter results handily topped estimates.
CVS Health's stock surges toward a one-year high after an earnings triple play
Shares of CVS Health Corp. CVS jumped 6.6% toward a one-year high in premarket trading Thursday, after the healthcare-services company and drugstore chain scored a triple-play with its earnings report...
CVS Health raises annual profit forecast as turnaround gathers steam
CVS Health raised its full-year profit forecast on Thursday following strong performance across its businesses, signalling an early recovery after a series of troubles hit the healthcare conglomerate ...
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
CVS Health said it will significantly expand access to the blockbuster weight loss drug Wegovy for patients covered by its pharmacy benefit manager, Caremark. Under a new partnership between Caremark ...
CVS tops estimates, hikes guidance as insurance business shows some improvement
CVS Health reported first-quarter revenue and profit that topped estimates and hiked its guidance, as its troubled insurance business showed some improvement during the period. The company now expect...
CVS Beats Wall Street Expectations, Plans to Withdraw From ACA Business
The healthcare company also struck a deal with Novo Nordisk to sell Wegovy at a reduced price for cash-paying customers through its pharmacies.
CVS HEALTH CORPORATION REPORTS FIRST QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE
First Quarter Financial Highlights Total revenues increased to $94.6 billion, up 7.0% compared to prior year GAAP diluted EPS of $1.41 and Adjusted EPS of $2.25 Generated cash flow from operations of ...
CVS Health Reports Earnings Thursday. The Stock Is Hot.
The stock has gained nearly 50% so far this year.
My Dividend Stock Portfolio: New All-Time Dividend Record In March - 100 Holdings With 15 Buys
March investments totaled around $1,200, mainly in BDCs like Blue Owl Capital and Ares Capital, boosting annual dividend income by $100. Dividend income hit a new all-time record of $1,404, up 17% Y/Y...
Dollar General has the same 'sole survivor' status as CVS Health, says Jim Cramer
'Mad Money' host Jim Cramer talks the comeback of Dollar General and CVS shares in recent months.
Biggest challenge for CVS last year was its Aetna managed care business, says Jim Cramer
'Mad Money' host Jim Cramer talks the comeback of Dollar General and CVS shares in recent months.
Shares of CVS and Dollar General made a turnaround due to their 'newfound sole survivor status,' Jim Cramer says
CNBC's Jim Cramer on Tuesday suggested why CVS and Dollar General have seen gains recently after lagging last year. He attributed the turnaround in part to the idea that these two have become the most...
CVS Health: Maybe The Right Investment At The Right Time
CVS Health Corporation surged 10% intraday and ended yesterday 6% higher, driven by a new CFO announcement and increased Medicare Advantage payments. Despite a challenging fiscal 2024, CVS is underval...
These 20 stocks have risen during Trump's trade tirade. Analysts see up to 30% additional upside.
The stock market doesn't react well to uncertainty. And the daily headlines about new tariffs being placed on U.S. imports and possible negotiations with trading partners to do away with tariffs have ...
Mizuho's Jared Holz: Here's why healthcare stocks are under pressure
Jared Holz, Mizuho Securities America healthcare sector strategist, joins CNBC's 'Power Lunch' to discuss whether the healthcare sector is actually a safe haven during the market turmoil, why healthca...
Measuring WBA Merger, HUM "Bonds Play," CVS & UNH Options Trades
Spencer Hakimian believes the healthcare sector will withstand the tariff storm well compared to other industries. On specific stocks, he doesn't expect much movement from Walgreens (WBA) after its to...